Details for: CKS2

Gene ID: 1164

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: CKS2

Ensembl ID: ENSG00000123975

Description: CDC28 protein kinase regulatory subunit 2

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 45.23
    rCSI 40.84%
    PRS 36.82
  • keratinocyte CL0000312
    CSI 40.76
    rCSI 34.16%
    PRS 45.11
  • transit amplifying cell of colon CL0009011
    CSI 34.36
    rCSI 40.36%
    PRS 43.86
  • double negative thymocyte CL0002489
    CSI 33.68
    rCSI 23.42%
    PRS 47.87
  • common myeloid progenitor CL0000049
    CSI 31.74
    rCSI 25.67%
    PRS 40.51
  • pro-B cell CL0000826
    CSI 31.62
    rCSI 26.18%
    PRS 40.87
  • promonocyte CL0000559
    CSI 29.75
    rCSI 50.96%
    PRS 49.12
  • stem cell CL0000034
    CSI 28
    rCSI 26.99%
    PRS 31.51
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 26.28
    rCSI 30.35%
    PRS 35.07
  • fraction A pre-pro B cell CL0002045
    CSI 24.22
    rCSI 27.72%
    PRS 62.64
  • large pre-B-II cell CL0000957
    CSI 24.06
    rCSI 68.68%
    PRS 54.73
  • promyelocyte CL0000836
    CSI 22.88
    rCSI 33.01%
    PRS 49.98
  • neural crest cell CL0011012
    CSI 22.69
    rCSI 17.94%
    PRS 28.98
  • vascular associated smooth muscle cell CL0000359
    CSI 21.12
    rCSI 68.49%
    PRS 43.45
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 19.95
    rCSI 26.14%
    PRS 52.74
  • endothelial cell of lymphatic vessel CL0002138
    CSI 18.92
    rCSI 37.49%
    PRS 64.96
  • epithelial cell of lung CL0000082
    CSI 18.87
    rCSI 15.65%
    PRS 38.57
  • radial glial cell CL0000681
    CSI 18.46
    rCSI 25.65%
    PRS 39.74
  • blood vessel endothelial cell CL0000071
    CSI 18.04
    rCSI 37.43%
    PRS 38.32
  • granulocyte monocyte progenitor cell CL0000557
    CSI 17.89
    rCSI 15.49%
    PRS 43.76
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 17.14
    rCSI 12.31%
    PRS 52.21
  • early lymphoid progenitor CL0000936
    CSI 17.01
    rCSI 14.94%
    PRS 44.78
  • hematopoietic stem cell CL0000037
    CSI 16.58
    rCSI 11.02%
    PRS 44.07
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 14.22
    rCSI 16.98%
    PRS 59.73
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 13.78
    rCSI 23.57%
    PRS 60.65
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 13.43
    rCSI 13.19%
    PRS 54.79
  • multi-ciliated epithelial cell CL0005012
    CSI 13.42
    rCSI 13.39%
    PRS 34.75
  • myeloid leukocyte CL0000766
    CSI 13.07
    rCSI 12.06%
    PRS 41.11
  • myofibroblast cell CL0000186
    CSI 12.99
    rCSI 18%
    PRS 45.67
  • innate lymphoid cell CL0001065
    CSI 12.65
    rCSI 26.11%
    PRS 47.27
  • colon epithelial cell CL0011108
    CSI 11.91
    rCSI 12.47%
    PRS 37.62
  • primitive red blood cell CL0002355
    CSI 11.42
    rCSI 61.64%
    PRS 55.13
  • melanocyte CL0000148
    CSI 11.24
    rCSI 8.32%
    PRS 34.4
  • common dendritic progenitor CL0001029
    CSI 11.22
    rCSI 14.08%
    PRS 49.18
  • T-helper 17 cell CL0000899
    CSI 10.97
    rCSI 8.71%
    PRS 61.36
  • intestinal epithelial cell CL0002563
    CSI 10.94
    rCSI 11.44%
    PRS 39.88
  • epithelial cell CL0000066
    CSI 10.44
    rCSI 16.04%
    PRS 43.4
  • transit amplifying cell CL0009010
    CSI 10.34
    rCSI 15.82%
    PRS 56.15
  • mesodermal cell CL0000222
    CSI 10.1
    rCSI 12.12%
    PRS 38.23
  • interneuron CL0000099
    CSI 9.99
    rCSI 20.05%
    PRS 30.94
  • T follicular helper cell CL0002038
    CSI 9.81
    rCSI 7.34%
    PRS 54.04
  • placental villous trophoblast CL2000060
    CSI 9.68
    rCSI 14.96%
    PRS 38.07
  • plasmacytoid dendritic cell, human CL0001058
    CSI 9.25
    rCSI 6.46%
    PRS 41.74
  • precursor B cell CL0000817
    CSI 8.75
    rCSI 7.66%
    PRS 49.46
  • mononuclear phagocyte CL0000113
    CSI 8.65
    rCSI 19.05%
    PRS 43.75
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 8.39
    rCSI 7.76%
    PRS 60.12
  • transit amplifying cell of small intestine CL0009012
    CSI 8.37
    rCSI 36.74%
    PRS 59.68
  • fallopian tube secretory epithelial cell CL4030006
    CSI 8.29
    rCSI 7.99%
    PRS 40.63
  • hematopoietic precursor cell CL0008001
    CSI 8.27
    rCSI 8.51%
    PRS 57.22
  • germinal center B cell CL0000844
    CSI 7.8
    rCSI 23.27%
    PRS 63.31
  • plasmablast CL0000980
    CSI 7.73
    rCSI 6.08%
    PRS 46
  • late pro-B cell CL0002048
    CSI 7.71
    rCSI 19.31%
    PRS 70.82
  • mature B cell CL0000785
    CSI 7.25
    rCSI 6.3%
    PRS 48.45
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 7.01
    rCSI 6.89%
    PRS 68.39
  • intestine goblet cell CL0019031
    CSI 6.9
    rCSI 6.12%
    PRS 39.26
  • granulocyte CL0000094
    CSI 6.84
    rCSI 10.45%
    PRS 48.65
  • unswitched memory B cell CL0000970
    CSI 6.72
    rCSI 5.66%
    PRS 56.88
  • mesenchymal stem cell CL0000134
    CSI 6.56
    rCSI 71.83%
    PRS 57.01
  • basal cell CL0000646
    CSI 6.55
    rCSI 8.76%
    PRS 41.76
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 6.42
    rCSI 33.17%
    PRS 63.9
  • forebrain radial glial cell CL0013000
    CSI 6.4
    rCSI 20.55%
    PRS 48.18
  • bronchus fibroblast of lung CL2000093
    CSI 6.04
    rCSI 4.91%
    PRS 41
  • basal cell of epidermis CL0002187
    CSI 6.02
    rCSI 10.67%
    PRS 25.45
  • pulmonary alveolar type 2 cell CL0002063
    CSI 5.97
    rCSI 9.25%
    PRS 50.19
  • group 3 innate lymphoid cell CL0001071
    CSI 5.91
    rCSI 4.44%
    PRS 43.03
  • glial cell CL0000125
    CSI 5.76
    rCSI 21.94%
    PRS 34.65
  • erythroid lineage cell CL0000764
    CSI 5.69
    rCSI 36.58%
    PRS 62.84
  • erythrocyte CL0000232
    CSI 5.48
    rCSI 12.43%
    PRS 45.76
  • small pre-B-II cell CL0000954
    CSI 5.29
    rCSI 5.09%
    PRS 63.79
  • deuterosomal cell CL4033044
    CSI 5.21
    rCSI 17.61%
    PRS 50.53
  • enteroendocrine cell CL0000164
    CSI 5.13
    rCSI 7.02%
    PRS 42.65
  • erythroid progenitor cell CL0000038
    CSI 5.1
    rCSI 29.25%
    PRS 50.96
  • goblet cell CL0000160
    CSI 4.97
    rCSI 4.7%
    PRS 41.2
  • immature B cell CL0000816
    CSI 4.81
    rCSI 3.57%
    PRS 52.51
  • muscle cell CL0000187
    CSI 4.71
    rCSI 9.67%
    PRS 62.53
  • intermediate monocyte CL0002393
    CSI 4.71
    rCSI 7.1%
    PRS 41.64
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 4.61
    rCSI 13.23%
    PRS 56.75
  • interstitial cell of Cajal CL0002088
    CSI 4.45
    rCSI 5.66%
    PRS 44.95
  • lung macrophage CL1001603
    CSI 4.31
    rCSI 9.63%
    PRS 46.04
  • colonocyte CL1000347
    CSI 4.28
    rCSI 6.13%
    PRS 47.56
  • respiratory basal cell CL0002633
    CSI 4.15
    rCSI 4.3%
    PRS 45.54
  • primordial germ cell CL0000670
    CSI 4.13
    rCSI 20.65%
    PRS 82.65
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 4.11
    rCSI 7.76%
    PRS 63.94
  • basophil CL0000767
    CSI 4.01
    rCSI 8.49%
    PRS 61.22
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 4
    rCSI 10.34%
    PRS 71.11
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 3.97
    rCSI 4.79%
    PRS 47.1
  • cerebral cortex endothelial cell CL1001602
    CSI 3.85
    rCSI 6.66%
    PRS 31.65
  • elicited macrophage CL0000861
    CSI 3.7
    rCSI 3.4%
    PRS 46.91
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 3.66
    rCSI 4.7%
    PRS 38.22
  • erythroblast CL0000765
    CSI 3.65
    rCSI 9.69%
    PRS 53.41
  • thymocyte CL0000893
    CSI 3.62
    rCSI 12.87%
    PRS 76.82
  • glioblast CL0000030
    CSI 3.52
    rCSI 5.62%
    PRS 34.56
  • epithelial cell of lower respiratory tract CL0002632
    CSI 3.5
    rCSI 2.72%
    PRS 40.21
  • mesenchymal cell CL0008019
    CSI 3.48
    rCSI 8.83%
    PRS 36.82
  • skin fibroblast CL0002620
    CSI 3.36
    rCSI 2.9%
    PRS 49.33
  • myeloid dendritic cell CL0000782
    CSI 3.24
    rCSI 4.69%
    PRS 55.59
  • colon goblet cell CL0009039
    CSI 3.22
    rCSI 7.65%
    PRS 52.47
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 3.07
    rCSI 3.13%
    PRS 52.28
  • intestinal tuft cell CL0019032
    CSI 3.02
    rCSI 4.62%
    PRS 44.38
  • basophil mast progenitor cell CL0002028
    CSI 2.9
    rCSI 15.47%
    PRS 79.16
  • prostate gland microvascular endothelial cell CL2000059
    CSI 0.2
    rCSI 4.8%
    PRS 68.4%
  • group 2 innate lymphoid cell CL0001069
    CSI 0.2
    rCSI 1.2%
    PRS 76.1%
  • epithelial cell of esophagus CL0002252
    CSI 0.4
    rCSI 3.5%
    PRS 68.7%
  • retinal cone cell CL0000573
    CSI 0.4
    rCSI 0.6%
    PRS 31.8%
  • vein endothelial cell of respiratory system CL4033008
    CSI 0.6
    rCSI 4.0%
    PRS 59.0%
  • respiratory epithelial cell CL0002368
    CSI 0.6
    rCSI 3.7%
    PRS 76.3%
  • memory T cell CL0000813
    CSI 0.7
    rCSI 1.4%
    PRS 69.6%
  • epithelial cell of nephron CL1000449
    CSI 0.7
    rCSI 6.9%
    PRS 81.8%
  • Langerhans cell CL0000453
    CSI 0.8
    rCSI 1.2%
    PRS 57.4%
  • chondrocyte CL0000138
    CSI 0.9
    rCSI 1.5%
    PRS 34.0%
  • B-2 B cell CL0000822
    CSI 1.0
    rCSI 20.5%
    PRS 81.8%
  • IgG plasma cell CL0000985
    CSI 1.0
    rCSI 1.2%
    PRS 58.6%
  • tracheobronchial serous cell CL0019001
    CSI 1.0
    rCSI 4.4%
    PRS 56.9%
  • intestinal crypt stem cell of colon CL0009043
    CSI 1.1
    rCSI 8.1%
    PRS 60.4%
  • foveolar cell of stomach CL0002179
    CSI 1.3
    rCSI 2.8%
    PRS 55.1%
  • type L enteroendocrine cell CL0002279
    CSI 1.3
    rCSI 2.4%
    PRS 60.2%
  • cord blood hematopoietic stem cell CL2000095
    CSI 1.3
    rCSI 25.1%
    PRS 88.3%
  • activated CD4-positive, alpha-beta T cell, human CL0001043
    CSI 1.3
    rCSI 3.2%
    PRS 83.7%
  • blood vessel smooth muscle cell CL0019018
    CSI 1.4
    rCSI 10.9%
    PRS 35.6%
  • small intestine goblet cell CL1000495
    CSI 1.4
    rCSI 3.0%
    PRS 49.8%
  • mammary gland epithelial cell CL0002327
    CSI 1.4
    rCSI 4.8%
    PRS 55.9%
  • T-helper 1 cell CL0000545
    CSI 1.4
    rCSI 2.5%
    PRS 67.2%
  • common lymphoid progenitor CL0000051
    CSI 1.4
    rCSI 1.9%
    PRS 62.5%
  • B-1 B cell CL0000819
    CSI 1.5
    rCSI 37.7%
    PRS 82.0%
  • paneth cell of epithelium of small intestine CL1000343
    CSI 1.5
    rCSI 4.1%
    PRS 54.8%
  • paneth cell CL0000510
    CSI 1.5
    rCSI 2.2%
    PRS 57.1%
  • megakaryocyte progenitor cell CL0000553
    CSI 1.5
    rCSI 27.1%
    PRS 75.0%
  • ciliated cell CL0000064
    CSI 1.5
    rCSI 2.4%
    PRS 38.9%
  • luminal cell of prostate epithelium CL0002340
    CSI 1.5
    rCSI 8.1%
    PRS 55.9%
  • epithelial cell of proximal tubule CL0002306
    CSI 1.5
    rCSI 3.7%
    PRS 36.7%
  • stratified epithelial cell CL0000079
    CSI 1.5
    rCSI 9.5%
    PRS 71.5%
  • natural T-regulatory cell CL0000903
    CSI 1.5
    rCSI 2.9%
    PRS 74.3%
  • kidney epithelial cell CL0002518
    CSI 1.6
    rCSI 3.0%
    PRS 63.2%
  • extravillous trophoblast CL0008036
    CSI 1.6
    rCSI 2.0%
    PRS 36.1%
  • endothelial cell of placenta CL0009092
    CSI 1.7
    rCSI 8.1%
    PRS 51.2%
  • respiratory suprabasal cell CL4033048
    CSI 1.7
    rCSI 2.2%
    PRS 44.6%
  • glandular epithelial cell CL0000150
    CSI 1.7
    rCSI 4.5%
    PRS 63.0%
  • dendritic cell, human CL0001056
    CSI 1.7
    rCSI 2.7%
    PRS 46.4%
  • type EC enteroendocrine cell CL0000577
    CSI 1.8
    rCSI 6.4%
    PRS 53.5%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 1.9
    rCSI 3.3%
    PRS 25.1%
  • IgA plasma cell CL0000987
    CSI 1.9
    rCSI 1.9%
    PRS 58.5%
  • alveolar macrophage CL0000583
    CSI 1.9
    rCSI 3.1%
    PRS 45.2%
  • BEST4+ enteroycte CL4030026
    CSI 1.9
    rCSI 2.4%
    PRS 42.5%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 1.9
    rCSI 4.6%
    PRS 57.2%
  • activated type II NK T cell CL0000931
    CSI 1.9
    rCSI 2.2%
    PRS 55.8%
  • lung secretory cell CL1000272
    CSI 2.0
    rCSI 4.9%
    PRS 38.2%
  • retinal blood vessel endothelial cell CL0002585
    CSI 2.0
    rCSI 3.2%
    PRS 43.3%
  • neural progenitor cell CL0011020
    CSI 2.0
    rCSI 8.8%
    PRS 34.7%
  • M cell of gut CL0000682
    CSI 2.0
    rCSI 2.1%
    PRS 55.4%
  • respiratory goblet cell CL0002370
    CSI 2.0
    rCSI 22.0%
    PRS 61.0%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 2.0
    rCSI 2.5%
    PRS 37.6%
  • respiratory hillock cell CL4030023
    CSI 2.0
    rCSI 3.6%
    PRS 55.9%
  • enteric smooth muscle cell CL0002504
    CSI 2.0
    rCSI 2.9%
    PRS 42.8%
  • peripheral nervous system neuron CL2000032
    CSI 2.0
    rCSI 2.8%
    PRS 34.4%
  • alternatively activated macrophage CL0000890
    CSI 2.0
    rCSI 2.6%
    PRS 53.1%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 2.1
    rCSI 1.4%
    PRS 49.4%
  • acinar cell CL0000622
    CSI 2.1
    rCSI 3.1%
    PRS 50.7%
  • neural cell CL0002319
    CSI 2.1
    rCSI 8.0%
    PRS 35.4%
  • megakaryocyte CL0000556
    CSI 2.1
    rCSI 9.3%
    PRS 55.8%
  • mucous neck cell CL0000651
    CSI 2.2
    rCSI 3.1%
    PRS 53.7%
  • pluripotent stem cell CL0002248
    CSI 2.2
    rCSI 64.9%
    PRS 65.2%
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 2.2
    rCSI 5.9%
    PRS 48.8%
  • enterocyte CL0000584
    CSI 2.2
    rCSI 3.5%
    PRS 49.5%
  • inflammatory macrophage CL0000863
    CSI 2.2
    rCSI 3.8%
    PRS 66.0%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 2.2
    rCSI 8.7%
    PRS 59.8%
  • duct epithelial cell CL0000068
    CSI 2.3
    rCSI 3.3%
    PRS 42.7%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 2.3
    rCSI 4.5%
    PRS 57.8%
  • myelocyte CL0002193
    CSI 2.4
    rCSI 15.6%
    PRS 74.1%
  • ciliated epithelial cell CL0000067
    CSI 2.4
    rCSI 2.1%
    PRS 30.3%
  • basal cell of prostate epithelium CL0002341
    CSI 2.4
    rCSI 7.0%
    PRS 59.0%
  • ON-bipolar cell CL0000749
    CSI 2.6
    rCSI 3.8%
    PRS 43.2%
  • pre-conventional dendritic cell CL0002010
    CSI 2.7
    rCSI 35.1%
    PRS 73.9%
  • syncytiotrophoblast cell CL0000525
    CSI 2.7
    rCSI 7.7%
    PRS 58.0%
  • lung ciliated cell CL1000271
    CSI 2.7
    rCSI 3.1%
    PRS 31.1%
  • renal alpha-intercalated cell CL0005011
    CSI 2.7
    rCSI 3.7%
    PRS 48.1%
  • Schwann cell CL0002573
    CSI 2.8
    rCSI 7.9%
    PRS 40.2%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 2.8
    rCSI 12.6%
    PRS 76.5%
  • dendritic cell CL0000451
    CSI 2.8
    rCSI 3.5%
    PRS 65.5%
  • eosinophil CL0000771
    CSI 2.8
    rCSI 18.5%
    PRS 71.5%
  • club cell CL0000158
    CSI 2.9
    rCSI 4.2%
    PRS 40.3%
  • skeletal muscle satellite cell CL0000594
    CSI 2.9
    rCSI 8.5%
    PRS 71.9%
  • basophil mast progenitor cell CL0002028
    CSI 2.9
    rCSI 15.5%
    PRS 79.2%
  • intestinal tuft cell CL0019032
    CSI 3.0
    rCSI 4.6%
    PRS 44.4%
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 3.1
    rCSI 3.1%
    PRS 52.3%
  • colon goblet cell CL0009039
    CSI 3.2
    rCSI 7.7%
    PRS 52.5%
  • myeloid dendritic cell CL0000782
    CSI 3.2
    rCSI 4.7%
    PRS 55.6%
  • skin fibroblast CL0002620
    CSI 3.4
    rCSI 2.9%
    PRS 49.3%
  • mesenchymal cell CL0008019
    CSI 3.5
    rCSI 8.8%
    PRS 36.8%
  • epithelial cell of lower respiratory tract CL0002632
    CSI 3.5
    rCSI 2.7%
    PRS 40.2%
  • glioblast CL0000030
    CSI 3.5
    rCSI 5.6%
    PRS 34.6%
  • thymocyte CL0000893
    CSI 3.6
    rCSI 12.9%
    PRS 76.8%
  • erythroblast CL0000765
    CSI 3.7
    rCSI 9.7%
    PRS 53.4%
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 3.7
    rCSI 4.7%
    PRS 38.2%
  • elicited macrophage CL0000861
    CSI 3.7
    rCSI 3.4%
    PRS 46.9%
  • cerebral cortex endothelial cell CL1001602
    CSI 3.9
    rCSI 6.7%
    PRS 31.7%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 4.0
    rCSI 4.8%
    PRS 47.1%
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 4.0
    rCSI 10.3%
    PRS 71.1%
  • basophil CL0000767
    CSI 4.0
    rCSI 8.5%
    PRS 61.2%
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 4.1
    rCSI 7.8%
    PRS 63.9%
  • primordial germ cell CL0000670
    CSI 4.1
    rCSI 20.7%
    PRS 82.7%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [CKS2](/details-gene/1164) (CDC28 protein kinase regulatory subunit 2) is a protein-coding gene located on chromosome 9q22.2. It encodes a regulatory subunit essential for the function of cyclin-dependent kinases (CDKs), which are central regulators of the cell cycle. Functionally, [CKS2](/details-gene/1164) is deeply involved in processes such as '[Cell division](/ontology/GO:0051301)' and '[Mitotic cell cycle phase transition](/ontology/GO:0044772)'. Its expression profile reflects this core function, showing high significance in a wide array of highly proliferative cell types, including various hematopoietic progenitors, epithelial transit-amplifying cells, and stem cells. Its role as a key component of the cell cycle machinery has been established in several studies ([Link](https://doi.org/10.1101/gad.4.8.1332), [Link](https://doi.org/10.1126/science.8211159)). ## Cellular Roles and Expression Landscape The expression pattern of [CKS2](/details-gene/1164) highlights its indispensable role in cell proliferation across multiple tissues. **Overall**, the gene exhibits its highest significance in populations of progenitor and stem cells characterized by rapid division. * **Hematopoietic Progenitors:** [CKS2](/details-gene/1164) is a prominent marker in various hematopoietic lineages, including [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) (CSI: 45.23), [common myeloid progenitor](/details-cell/CL0000049) (CSI: 31.74), [pro-B cell](/details-cell/CL0000826) (CSI: 31.62), and [promonocyte](/details-cell/CL0000559) (CSI: 29.75). This broad expression across myeloid and lymphoid precursors suggests a fundamental role in the expansion phases of hematopoiesis. * **Epithelial and Tissue Progenitors:** The gene is also highly significant in epithelial cells responsible for tissue turnover and regeneration, such as [keratinocyte](/details-cell/CL0000312) (CSI: 40.76) in the skin and [transit amplifying cell of colon](/details-cell/CL0009011) (CSI: 34.36) in the gut. This is consistent with its function in driving proliferation to maintain tissue homeostasis. * **Stem and Developmental Cells:** High significance is observed in undifferentiated [stem cell](/details-cell/CL0000034) populations (CSI: 28.00) as well as developmental precursors like [neuroblast (sensu Nematoda and Protostomia)](/details-cell/CL0000338) (CSI: 26.28) and [neural crest cell](/details-cell/CL0011012) (CSI: 22.69). This pattern underscores its importance during embryonic development and in maintaining stem cell pools. The collective data indicate that [CKS2](/details-gene/1164) is not a marker of a specific lineage but rather a functional marker of a cell's proliferative state. ## Pathways and Molecular Function The functions of [CKS2](/details-gene/1164) are intrinsically linked to the regulation and execution of the cell cycle. As a core component of the [Cyclin-dependent protein kinase holoenzyme complex](/ontology/GO:0000307), its primary molecular function is '[Cyclin-dependent protein serine/threonine kinase activator activity](/ontology/GO:0061575)'. Biologically, it plays a critical role in the '[Regulation of mitotic cell cycle](/ontology/GO:0007346)' and is essential for key transitions, particularly during '[Meiosis i](/ontology/GO:0007127)' and general '[Mitotic cell cycle phase transition](/ontology/GO:0044772)'. Its involvement extends to protein degradation pathways necessary for cell cycle progression, as evidenced by its association with the '[Scf ubiquitin ligase complex](/ontology/GO:0019005)' and its ability for '[Ubiquitin binding](/ontology/GO:0043130)'. Furthermore, its capacity for '[Chromatin binding](/ontology/GO:0003682)' and '[Histone binding](/ontology/GO:0042393)' suggests a role in coordinating chromatin dynamics with cell division. Early research elucidated its atomic structure and proposed a role for its hexameric assembly in mediating these cell cycle control functions ([Link](https://doi.org/10.1126/science.8211159)). ## Research Directions The widespread expression of [CKS2](/details-gene/1164) in proliferating cells, especially in cancer, makes it a subject of significant interest. Its fundamental role in cell division provides clear avenues for future investigation. **Proposed Hypotheses:** 1. Given its high expression across multiple hematopoietic progenitor populations ([megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050), [common myeloid progenitor](/details-cell/CL0000049)), knockdown or inhibition of [CKS2](/details-gene/1164) may force progenitor cells out of the cell cycle, leading to premature differentiation or apoptosis and thereby disrupting normal hematopoiesis. 2. The high significance of [CKS2](/details-gene/1164) in epithelial progenitors like [keratinocyte](/details-cell/CL0000312) and [transit amplifying cell of colon](/details-cell/CL0009011) suggests it is a critical node for tissue regeneration. It is hypothesized that [CKS2](/details-gene/1164) levels must be precisely regulated to balance proliferation and differentiation, and its dysregulation could contribute to inflammatory diseases or impaired wound healing in these tissues. **Experimental Approach:** To test the first hypothesis regarding the role of [CKS2](/details-gene/1164) in hematopoiesis, a conditional knockout mouse model could be employed (e.g., Cks2-floxed mice crossed with Vav1-Cre or Mx1-Cre mice to achieve hematopoietic-specific deletion). Following deletion, bone marrow from these mice could be analyzed via flow cytometry to quantify hematopoietic stem and progenitor cell populations. Functional assays, such as in vitro colony-forming unit (CFU) assays and in vivo competitive bone marrow transplantation, would directly assess the impact of [CKS2](/details-gene/1164) loss on the self-renewal and differentiation capacity of hematopoietic progenitors. **Therapeutic Potential:** As a key driver of cell proliferation, [CKS2](/details-gene/1164) represents a compelling target for anti-cancer therapies. Its role as a kinase regulatory subunit makes it amenable to targeting with small molecule inhibitors. The therapeutic strategy would be **inhibition** to induce cell cycle arrest in rapidly dividing cancer cells. However, its high expression in normal progenitor cells (e.g., in bone marrow and gut epithelium) predicts a narrow therapeutic window. Systemic inhibition would likely cause significant on-target toxicities, such as myelosuppression and mucositis. Therefore, developing strategies to selectively deliver inhibitors to tumor cells or identifying cancer-specific dependencies on [CKS2](/details-gene/1164) would be critical for its clinical translation.

Genular Protein ID: 743374517

Symbol: CKS2_HUMAN

Name: Cyclin-dependent kinases regulatory subunit 2

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 2227411

Title: Human cDNAs encoding homologs of the small p34Cdc28/Cdc2-associated protein of Saccharomyces cerevisiae and Schizosaccharomyces pombe.

PubMed ID: 2227411

DOI: 10.1101/gad.4.8.1332

PubMed ID: 15164053

Title: DNA sequence and analysis of human chromosome 9.

PubMed ID: 15164053

DOI: 10.1038/nature02465

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 8211159

Title: Human CksHs2 atomic structure: a role for its hexameric assembly in cell cycle control.

PubMed ID: 8211159

DOI: 10.1126/science.8211159

Sequence Information:

  • Length: 79
  • Mass: 9860
  • Checksum: 811B5927691EEC5C
  • Sequence:
  • MAHKQIYYSD KYFDEHYEYR HVMLPRELSK QVPKTHLMSE EEWRRLGVQQ SLGWVHYMIH 
    EPEPHILLFR RPLPKDQQK